MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.080
-0.030 (-2.70%)
Aug 5, 2026, 2:57 PM EDT - Market open
MaxCyte Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 14.56 | 20.07 | 27.88 | 46.51 | 11.07 | 47.78 |
Short-Term Investments | 92.3 | 82.98 | 126.6 | 121.78 | 216.28 | 207.26 |
Cash & Short-Term Investments | 106.85 | 103.04 | 154.48 | 168.29 | 227.34 | 255.04 |
Cash Growth | -22.72% | -33.30% | -8.20% | -25.97% | -10.86% | 633.67% |
Accounts Receivable | 4.25 | 3.5 | 4.68 | 5.78 | 13.09 | 6.88 |
Inventory | 7.63 | 7.55 | 8.91 | 12.23 | 8.58 | 5.2 |
Other Current Assets | 4.21 | 4.28 | 3.61 | 3.9 | 3.26 | 3.31 |
Total Current Assets | 122.94 | 118.37 | 171.68 | 190.19 | 252.27 | 270.43 |
Net Property, Plant & Equipment | 27.34 | 28.45 | 30.47 | 34.75 | 33.58 | 13.37 |
Other Intangible Assets | 0.78 | 0.65 | - | - | - | - |
Long-Term Investments | 40.81 | 52.57 | 35.78 | 42.94 | - | - |
Other Long-Term Assets | 2.61 | 2.47 | 1.53 | 0.39 | 0.81 | 0.32 |
Total Assets | 194.47 | 202.51 | 239.47 | 268.27 | 286.65 | 284.12 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.2 | 1.4 | 1.36 | 0.74 | 0.29 | 1.82 |
Accrued Expenses | 4.37 | 7.81 | 8.3 | 11.27 | 8.27 | 6.52 |
Current Portion of Leases | 1.37 | 1.46 | 0.86 | 0.77 | 0.16 | 0.53 |
Unearned Revenue | 3.27 | 3.6 | 5.25 | 5.07 | 6.71 | 6.75 |
Total Current Liabilities | 10.21 | 14.27 | 15.78 | 17.86 | 15.43 | 15.62 |
Long-Term Leases | 16.11 | 16.49 | 17.17 | 17.97 | 15.94 | 5.15 |
Other Long-Term Liabilities | 0.26 | 0.26 | 0.27 | 0.28 | 1.32 | 0.45 |
Total Long-Term Liabilities | 16.38 | 16.75 | 17.44 | 18.25 | 17.26 | 5.61 |
Total Liabilities | 26.59 | 31.02 | 33.22 | 36.11 | 32.69 | 21.22 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.07 | 1.07 | 1.06 | 1.04 | 1.02 | 1.01 |
Additional Paid-in Capital | 433.05 | 431.91 | 422.05 | 406.93 | 390.82 | 376.19 |
Retained Earnings | -266.23 | -261.48 | -216.85 | -175.8 | -137.88 | -114.3 |
Shareholders' Equity | 167.89 | 171.49 | 206.25 | 232.17 | 253.97 | 262.9 |
Total Liabilities & Equity | 194.47 | 202.51 | 239.47 | 268.27 | 286.65 | 284.12 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 17.49 | 17.94 | 18.03 | 18.74 | 16.1 | 5.68 |
Net Cash (Debt) | 89.37 | 85.1 | 136.45 | 149.55 | 211.25 | 249.36 |
Net Cash Growth | -25.18% | -37.63% | -8.76% | -29.21% | -15.29% | 789.36% |
Net Cash Per Share | 0.84 | 0.80 | 1.30 | 1.45 | 2.08 | 2.75 |
Book Value | 167.89 | 171.49 | 206.25 | 232.17 | 253.97 | 262.9 |
Book Value Per Share | 1.57 | 1.61 | 1.97 | 2.25 | 2.50 | 2.90 |
Tangible Book Value | 167.1 | 170.84 | 206.25 | 232.17 | 253.97 | 262.9 |
Tangible Book Value Per Share | 1.57 | 1.61 | 1.97 | 2.25 | 2.50 | 2.90 |